生物制剂和CGT产品
Search documents
8月14日康龙化成AH溢价达46.69%,位居AH股溢价率第74位
Jin Rong Jie· 2025-08-14 09:54
Core Viewpoint - The article discusses the performance of the Shanghai Composite Index and the Hang Seng Index on August 14, highlighting the stock price movements of Kanglong Chemical, a key player in the life sciences industry, and its A/H share premium status [1]. Group 1: Market Performance - On August 14, the Shanghai Composite Index fell by 0.46%, closing at 3666.44 points, while the Hang Seng Index decreased by 0.37%, closing at 25519.32 points [1]. Group 2: Company Overview - Kanglong Chemical (stock code: 300759.SZ/3759.HK) is a major service provider in the life sciences sector, established in 2004. The company has invested in talent and facilities, developing extensive research, development, and production capabilities across drug discovery, preclinical, and clinical development [1]. - The company offers a range of therapeutic approaches, including small molecules, biologics, and CGT products, and has a strong track record in providing R&D solutions for partners in North America, Europe, Japan, and China [1]. Group 3: A/H Share Premium - Kanglong Chemical's A/H share premium reached 46.69%, ranking it 74th among A/H shares. As of the close, the A-share price was 30.17 yuan, down by 2.17%, while the H-share price was 22.5 Hong Kong dollars, up by 1.26% [1].